找到约 10 条 “99-93-4” 相关结果 （用时 0.307 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
| M7449 | UCL 1684 | UCL 1684 | Others |
| UCL 1684 is a highly potent blocker of K Ca2. | |||
| M12501 | ChemBridge-5999308 | ChemBridge化合物-5999308 | Screening Compounds and Building Blocks |
| 1-(4-ethoxyphenyl)-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-2,4,6(1H,3H,5H)-pyrimidinetrione (5999308) | |||
| ChemBridge特有类药化合物/先导化合物-5999308，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M12714 | ChemBridge-6599493 | ChemBridge化合物-6599493 | Screening Compounds and Building Blocks |
| 4-[2-(4-hydroxyphenyl)-1,3-thiazol-4-yl]-1,2-benzenediol (6599493) | |||
| ChemBridge特有类药化合物/先导化合物-6599493，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13150 | ChemBridge-7999344 | ChemBridge化合物-7999344 | Screening Compounds and Building Blocks |
| 5-amino-2-butyl-7-[4-(dimethylamino)phenyl]-4,7-dihydro[1,3]oxazolo[5,4-b]pyridine-6-carbonitrile (7999344) | |||
| ChemBridge特有类药化合物/先导化合物-7999344，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13334 | ChemBridge-99441193 | ChemBridge化合物-99441193 | Screening Compounds and Building Blocks |
| N-{[1-(1H-imidazol-4-ylmethyl)pyrrolidin-3-yl]methyl}-8-methylimidazo[1,2-a]pyridine-2-carboxamide (99441193) | |||
| ChemBridge特有类药化合物/先导化合物-99441193，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
M17165
|
p-Hydroxyacetophenone | 对羟基苯乙酮 | Phenols |
| p-Hydroxyacetophenone 对羟基苯乙酮 | |||
| M18194 | (4S)-4-Hydroxy-L-isoleucine | (4S)-4-羟基-L-异亮氨酸 | Others |
| (2S,3R,4S)-4-Hydroxyisoleucine 是从胡卢巴中分离得到的一种可口服的有效成分，具有抗糖尿病、抗糖尿病肾病的活性。 | |||
| M20312 | WAY-299562 | WAY-299562 | PKA |
| WAY-299562 is a modulator of the interaction of protein kinase A (PKA) and A kinase anchor proteins (AKAP). | |||
| M56210 | Immethridine dihydrobromide | Immethridine dihydrobromide | Histamine Receptor |
| Immethridine dihydrobromide 是一种选择性组胺 H3 受体 (H3R) 激动剂。Immethridine dihydrobromide 对 H4 受体的选择性是 H4 受体的 300 倍，并且不与 H1 或 H2 受体结合。 | |||
| M21035 | LCH-7749944 | LCH-7749944 | PAK |
| GNF-PF-2356 | |||
| LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4. | |||
